Skip to main content
Top
Published in: Inflammation 3/2018

01-06-2018 | ORIGINAL ARTICLE

Anti-Inflammatory Effects of Hypophyllanthin and Niranthin Through Downregulation of NF-κB/MAPKs/PI3K-Akt Signaling Pathways

Authors: Hemavathy Harikrishnan, Ibrahim Jantan, Md. Areeful Haque, Endang Kumolosasi

Published in: Inflammation | Issue 3/2018

Login to get access

Abstract

Hypophyllanthin (HYP) and niranthin (NIR) are major lignans in Phyllanthus spp. and have been shown to possess strong anti-inflammatory activity. In this study, we investigated the anti-inflammatory effects and the underlying molecular mechanisms of HYP and NIR in in vitro cellular model of LPS-induced U937 macrophages. The effects of HYP and NIR on the production of prostaglandin E2 (PGE2), cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) were measured by using ELISA, Western blot, and qRT-PCR. The expressions of signaling molecules related to nuclear factor-kappa B (NF-κB), mitogen-activated protein kinases (MAPKs), and phosphatidylinositol 3′-kinase-Akt (PI3K-Akt) signaling pathways were examined. The role of NF-κB, MAPKs, and Akt signaling pathways was confirmed by using specific inhibitors (BAY 11-7082, U0126, SB202190, SP600125, and LY294002) mediated suppression of TNF-α and COX-2 production. HYP and NIR significantly inhibited the protein and gene levels of COX-2 as well as the downstream signaling products of PGE2, TNF-α, and IL-1β. HYP and NIR also suppressed the inhibitors of kappa B (IκB), IkB kinases (Ikkα/β), NF-κB phosphorylation, and IκB degradation. HYP suppressed the phosphorylation of c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38 while NIR only suppressed JNK and ERK but did not have effect on p38. These results demonstrate that HYP and NIR downregulated COX-2, TNF-α, and IL-1β gene expressions in U937 macrophages by interfering with the activation of NF-κB, MAPKs, and Akt. In conclusion, these lignans have potential to be developed as anti-inflammatory agents targeting the NF-κB, MAPK, and PI3K-Akt pathways.
Literature
1.
go back to reference Lawrence, T., D.A. Willoughby, and D.W. Gilroy. 2002. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nature Reviews. Immunology 10: 787–795.CrossRef Lawrence, T., D.A. Willoughby, and D.W. Gilroy. 2002. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nature Reviews. Immunology 10: 787–795.CrossRef
2.
go back to reference Wu, H., G. Zhao, K. Jiang, C. Li, C. Qiu, and G. Deng. 2016. Engeletin alleviates lipopolysaccharide-induced endometritis in mice by inhibiting TLR4-mediated NF-κB activation. Journal of Agricultural and Food Chemistry 31: 6171–6178.CrossRef Wu, H., G. Zhao, K. Jiang, C. Li, C. Qiu, and G. Deng. 2016. Engeletin alleviates lipopolysaccharide-induced endometritis in mice by inhibiting TLR4-mediated NF-κB activation. Journal of Agricultural and Food Chemistry 31: 6171–6178.CrossRef
3.
go back to reference Tao, J.Y., G.H. Zheng, L. Zhao, J.G. Wu, X.Y. Zhang, S.L. Zhang, Z.J. Huang, F.L. Xiong, and C.M. Li. 2009. Anti-inflammatory effects of ethyl acetate fraction from Melilotus suaveolens Ledeb on LPS-stimulated RAW 264.7 cells. Journal of Ethnopharmacology 1: 97–105.CrossRef Tao, J.Y., G.H. Zheng, L. Zhao, J.G. Wu, X.Y. Zhang, S.L. Zhang, Z.J. Huang, F.L. Xiong, and C.M. Li. 2009. Anti-inflammatory effects of ethyl acetate fraction from Melilotus suaveolens Ledeb on LPS-stimulated RAW 264.7 cells. Journal of Ethnopharmacology 1: 97–105.CrossRef
4.
go back to reference Rietschel, E.T., T. Kirikae, F.U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A.J. Ulmer, U. Zahringer, U. Seydel, F. Di Padova, et al. 1994. Bacterial endotoxin: Molecular relationships of structure to activity and function. FASEB Journal 2: 217–225.CrossRef Rietschel, E.T., T. Kirikae, F.U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A.J. Ulmer, U. Zahringer, U. Seydel, F. Di Padova, et al. 1994. Bacterial endotoxin: Molecular relationships of structure to activity and function. FASEB Journal 2: 217–225.CrossRef
5.
go back to reference Carralot, J.P., T.K. Kim, B. Lenseigne, A.S. Boese, P. Sommer, A. Genovesio, and P. Brodin. 2009. Automated high-throughput siRNA transfection in raw 264.7 macrophages: A case study for optimization procedure. Journal of Biomolecular Screening 2: 151–160.CrossRef Carralot, J.P., T.K. Kim, B. Lenseigne, A.S. Boese, P. Sommer, A. Genovesio, and P. Brodin. 2009. Automated high-throughput siRNA transfection in raw 264.7 macrophages: A case study for optimization procedure. Journal of Biomolecular Screening 2: 151–160.CrossRef
6.
go back to reference Mueller, M., V. Beck, and A. Jungbauer. 2011. PPARalpha activation by culinary herbs and spices. Planta Medica 5: 497–504.CrossRef Mueller, M., V. Beck, and A. Jungbauer. 2011. PPARalpha activation by culinary herbs and spices. Planta Medica 5: 497–504.CrossRef
7.
go back to reference Raetz, C.R., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annual Review of Biochemistry 71: 635–700.CrossRefPubMed Raetz, C.R., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annual Review of Biochemistry 71: 635–700.CrossRefPubMed
8.
go back to reference Zhou, W., J. Wang, Z. Li, J. Li, and M. Sang. 2016. MicroRNA-205-5b inhibits HMGB1 expression in LPS-induced sepsis. International Journal of Molecular Medicine 1: 312–318.CrossRef Zhou, W., J. Wang, Z. Li, J. Li, and M. Sang. 2016. MicroRNA-205-5b inhibits HMGB1 expression in LPS-induced sepsis. International Journal of Molecular Medicine 1: 312–318.CrossRef
9.
go back to reference Laveti, D., M. Kumar, R. Hemalatha, R. Sistla, V.G. Naidu, V. Talla, V. Verma, N. Kaur, and R. Nagpal. 2013. Anti-inflammatory treatments for chronic diseases: A review. Inflammation & Allergy Drug Targets 5: 349–361.CrossRef Laveti, D., M. Kumar, R. Hemalatha, R. Sistla, V.G. Naidu, V. Talla, V. Verma, N. Kaur, and R. Nagpal. 2013. Anti-inflammatory treatments for chronic diseases: A review. Inflammation & Allergy Drug Targets 5: 349–361.CrossRef
10.
go back to reference Zhang, G., and S. Ghosh. 2001. Toll-like receptor-mediated NF-kappaB activation: A phylogenetically conserved paradigm in innate immunity. The Journal of Clinical Investigation 1: 13–19.CrossRef Zhang, G., and S. Ghosh. 2001. Toll-like receptor-mediated NF-kappaB activation: A phylogenetically conserved paradigm in innate immunity. The Journal of Clinical Investigation 1: 13–19.CrossRef
11.
go back to reference Haque, M.A., I. Jantan, and H. Harikrishnan. 2018. Zerumbone suppresses the activation of inflammatory mediators in LPS-stimulated U937 macrophages through MyD88-dependent NF-κB/MAPK/PI3K-Akt signaling pathways. International Immunopharmacology 55: 312–322.CrossRefPubMed Haque, M.A., I. Jantan, and H. Harikrishnan. 2018. Zerumbone suppresses the activation of inflammatory mediators in LPS-stimulated U937 macrophages through MyD88-dependent NF-κB/MAPK/PI3K-Akt signaling pathways. International Immunopharmacology 55: 312–322.CrossRefPubMed
12.
go back to reference Tabas, I., and C.K. Glass. 2013. Anti-inflammatory therapy in chronic disease: Challenges and opportunities. Science 6116: 166–172.CrossRef Tabas, I., and C.K. Glass. 2013. Anti-inflammatory therapy in chronic disease: Challenges and opportunities. Science 6116: 166–172.CrossRef
13.
go back to reference Nathan, C., and A. Ding. 2010. Nonresolving inflammation. Cell 6: 871–882.CrossRef Nathan, C., and A. Ding. 2010. Nonresolving inflammation. Cell 6: 871–882.CrossRef
14.
go back to reference Ma, Y., Y. Bao, S. Wang, T. Li, X. Chang, G. Yang, and X. Meng. 2016. Anti-inflammation effects and potential mechanism of saikosaponins by regulating nicotinate and nicotinamide metabolism and arachidonic acid metabolism. Inflammation 4: 1453–1461.CrossRef Ma, Y., Y. Bao, S. Wang, T. Li, X. Chang, G. Yang, and X. Meng. 2016. Anti-inflammation effects and potential mechanism of saikosaponins by regulating nicotinate and nicotinamide metabolism and arachidonic acid metabolism. Inflammation 4: 1453–1461.CrossRef
15.
go back to reference Lin, L., and K. Hu. 2014. Tissue plasminogen activator and inflammation: From phenotype to signaling mechanisms. American Journal of Clinical and Experimental Immunology 1: 30–36. Lin, L., and K. Hu. 2014. Tissue plasminogen activator and inflammation: From phenotype to signaling mechanisms. American Journal of Clinical and Experimental Immunology 1: 30–36.
16.
go back to reference Patel, J.R., P. Tripathi, V. Sharma, N.S. Chauhan, and V.K. Dixit. 2011. Phyllanthus amarus: Ethnomedicinal uses, phytochemistry and pharmacology: A review. Journal of Ethnopharmacology 2: 286–313.CrossRef Patel, J.R., P. Tripathi, V. Sharma, N.S. Chauhan, and V.K. Dixit. 2011. Phyllanthus amarus: Ethnomedicinal uses, phytochemistry and pharmacology: A review. Journal of Ethnopharmacology 2: 286–313.CrossRef
17.
go back to reference Gottlieb, O.R. 1991. The rational search for natural neolignans. Memorias do Instituto Oswaldo Cruz 86: 25–29.CrossRefPubMed Gottlieb, O.R. 1991. The rational search for natural neolignans. Memorias do Instituto Oswaldo Cruz 86: 25–29.CrossRefPubMed
18.
go back to reference Kassuya, C.A., D.F. Leite, L.V. de Melo, V.L. Rehder, and J.B. Calixto. 2005. Anti-inflammatory properties of extracts, fractions and lignans isolated from Phyllanthus amarus. Planta Medica 8: 721–726.CrossRef Kassuya, C.A., D.F. Leite, L.V. de Melo, V.L. Rehder, and J.B. Calixto. 2005. Anti-inflammatory properties of extracts, fractions and lignans isolated from Phyllanthus amarus. Planta Medica 8: 721–726.CrossRef
19.
go back to reference Kiran, P.M., and B.G. Rao. 2013. Evaluation of anti-inflammatory activity of different extracts and isolated lignans of Phyllanthus amarus Schum. & Thonn. Aerial parts. International Journal of Pharma and Bio Sciences 4: 803–808. Kiran, P.M., and B.G. Rao. 2013. Evaluation of anti-inflammatory activity of different extracts and isolated lignans of Phyllanthus amarus Schum. & Thonn. Aerial parts. International Journal of Pharma and Bio Sciences 4: 803–808.
20.
go back to reference Kassuya, C.A.L., A. Silvestre, O. Menezes-de-Lima Jr., D.M. Marotta, V.L.G. Rehder, and J.B. Calixto. 2006. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus: Evidence for interaction with platelet activating factor receptor. European Journal of Pharmacology 1–3: 182–188.CrossRef Kassuya, C.A.L., A. Silvestre, O. Menezes-de-Lima Jr., D.M. Marotta, V.L.G. Rehder, and J.B. Calixto. 2006. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus: Evidence for interaction with platelet activating factor receptor. European Journal of Pharmacology 1–3: 182–188.CrossRef
21.
go back to reference Islam, A., T. Selvan, U. Mazumder, M. Gupta, and S. Ghosal. 2008. Antitumour effect of phyllanthin and hypophyllanthin from Phyllanthus amarus against Ehrlich ascites carcinoma in mice. Pharmacology: 796–807. Islam, A., T. Selvan, U. Mazumder, M. Gupta, and S. Ghosal. 2008. Antitumour effect of phyllanthin and hypophyllanthin from Phyllanthus amarus against Ehrlich ascites carcinoma in mice. Pharmacology: 796–807.
22.
go back to reference Jantan, I., M. Ilangkovan, and H.F. Mohamad. 2014. Correlation between the major components of Phyllanthus amarus and Phyllanthus urinaria and their inhibitory effects on phagocytic activity of human neutrophils. BMC Complementary and Alternative Medicine 1: 429.CrossRef Jantan, I., M. Ilangkovan, and H.F. Mohamad. 2014. Correlation between the major components of Phyllanthus amarus and Phyllanthus urinaria and their inhibitory effects on phagocytic activity of human neutrophils. BMC Complementary and Alternative Medicine 1: 429.CrossRef
23.
go back to reference Yuandani, I.J., M. Ilangkovan, K. Husain, and K.M. Chan. 2016. Inhibitory effects of compounds from Phyllanthus amarus on nitric oxide production, lymphocyte proliferation, and cytokine release from phagocytes. Drug Design, Development and Therapy 10: 1935.PubMedPubMedCentral Yuandani, I.J., M. Ilangkovan, K. Husain, and K.M. Chan. 2016. Inhibitory effects of compounds from Phyllanthus amarus on nitric oxide production, lymphocyte proliferation, and cytokine release from phagocytes. Drug Design, Development and Therapy 10: 1935.PubMedPubMedCentral
24.
go back to reference Saponaro, C., A. Cianciulli, R. Calvello, T. Dragone, F. Iacobazzi, and M.A. Panaro. 2012. The PI3K/Akt pathway is required for LPS activation of microglial cells. Immunopharmacology and Immunotoxicology 5: 858–865.CrossRef Saponaro, C., A. Cianciulli, R. Calvello, T. Dragone, F. Iacobazzi, and M.A. Panaro. 2012. The PI3K/Akt pathway is required for LPS activation of microglial cells. Immunopharmacology and Immunotoxicology 5: 858–865.CrossRef
25.
go back to reference Kaminska, B. 2005. MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits. Biochimica et Biophysica Acta 1–2: 253–262.CrossRef Kaminska, B. 2005. MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits. Biochimica et Biophysica Acta 1–2: 253–262.CrossRef
26.
go back to reference Tham, C.L., C.Y. Liew, K.W. Lam, A.-S. Mohamad, M.K. Kim, Y.K. Cheah, Z.-A. Zakaria, M.-R. Sulaiman, N.H. Lajis, and D.A. Israf. 2010. A synthetic curcuminoid derivative inhibits nitric oxide and proinflammatory cytokine synthesis. European Journal of Pharmacology 1: 247–254.CrossRef Tham, C.L., C.Y. Liew, K.W. Lam, A.-S. Mohamad, M.K. Kim, Y.K. Cheah, Z.-A. Zakaria, M.-R. Sulaiman, N.H. Lajis, and D.A. Israf. 2010. A synthetic curcuminoid derivative inhibits nitric oxide and proinflammatory cytokine synthesis. European Journal of Pharmacology 1: 247–254.CrossRef
27.
go back to reference Bertholet, S., E. Tzeng, E. Felley-Bosco, and J. Mauel. 1999. Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. Journal of Leukocyte Biology 1: 50–58.CrossRef Bertholet, S., E. Tzeng, E. Felley-Bosco, and J. Mauel. 1999. Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. Journal of Leukocyte Biology 1: 50–58.CrossRef
29.
go back to reference Zhang, H., Y. Shan, Y. Wu, C. Xu, X. Yu, J. Zhao, J. Yan, and W. Shang. 2017. Berberine suppresses Lps-induced inflammation through modulating Sirt1/nf-κb signaling pathway in Raw264. 7 cells. International Immunopharmacology 52: 93–100.CrossRefPubMed Zhang, H., Y. Shan, Y. Wu, C. Xu, X. Yu, J. Zhao, J. Yan, and W. Shang. 2017. Berberine suppresses Lps-induced inflammation through modulating Sirt1/nf-κb signaling pathway in Raw264. 7 cells. International Immunopharmacology 52: 93–100.CrossRefPubMed
30.
go back to reference Biswas, R., and A. Bagchi. 2016. NFkB pathway and inhibition: An overview. Computational Molecular Biology 6. Biswas, R., and A. Bagchi. 2016. NFkB pathway and inhibition: An overview. Computational Molecular Biology 6.
31.
go back to reference Zhang, Y.L., and C. Dong. 2005. MAP kinases in immune responses. Cellular & Molecular Immunology 1: 20–27. Zhang, Y.L., and C. Dong. 2005. MAP kinases in immune responses. Cellular & Molecular Immunology 1: 20–27.
32.
go back to reference Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cellular Signalling 2: 85–94.CrossRef Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cellular Signalling 2: 85–94.CrossRef
33.
go back to reference Lee, H.S., D.S. Ryu, G.S. Lee, and D.S. Lee. 2012. Anti-inflammatory effects of dichloromethane fraction from Orostachys japonicus in RAW 264.7 cells: Suppression of NF-kappaB activation and MAPK signaling. Journal of Ethnopharmacology 2: 271–276.CrossRef Lee, H.S., D.S. Ryu, G.S. Lee, and D.S. Lee. 2012. Anti-inflammatory effects of dichloromethane fraction from Orostachys japonicus in RAW 264.7 cells: Suppression of NF-kappaB activation and MAPK signaling. Journal of Ethnopharmacology 2: 271–276.CrossRef
34.
go back to reference Yu, H.Y., K.S. Kim, Y.C. Lee, H.I. Moon, and J.H. Lee. 2012. Oleifolioside A, a new active compound, attenuates LPS-stimulated iNOS and COX-2 expression through the downregulation of NF-kappaB and MAPK activities in RAW 264.7 macrophages. Evidence-based Complementary and Alternative Medicine 2012: 637512.PubMedPubMedCentral Yu, H.Y., K.S. Kim, Y.C. Lee, H.I. Moon, and J.H. Lee. 2012. Oleifolioside A, a new active compound, attenuates LPS-stimulated iNOS and COX-2 expression through the downregulation of NF-kappaB and MAPK activities in RAW 264.7 macrophages. Evidence-based Complementary and Alternative Medicine 2012: 637512.PubMedPubMedCentral
35.
go back to reference Wang, Z., W. Jiang, Z. Zhang, M. Qian, and B. Du. 2012. Nitidine chloride inhibits LPS-induced inflammatory cytokines production via MAPK and NF-kappaB pathway in RAW 264.7 cells. Journal of Ethnopharmacology 1: 145–150.CrossRef Wang, Z., W. Jiang, Z. Zhang, M. Qian, and B. Du. 2012. Nitidine chloride inhibits LPS-induced inflammatory cytokines production via MAPK and NF-kappaB pathway in RAW 264.7 cells. Journal of Ethnopharmacology 1: 145–150.CrossRef
36.
go back to reference Kotlyarov, A., A. Neininger, C. Schubert, R. Eckert, C. Birchmeier, H.D. Volk, and M. Gaestel. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nature Cell Biology 2: 94–97. Kotlyarov, A., A. Neininger, C. Schubert, R. Eckert, C. Birchmeier, H.D. Volk, and M. Gaestel. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nature Cell Biology 2: 94–97.
37.
go back to reference Qin, L.H., L. Kong, G.J. Shi, Z.T. Wang, and B.X. Ge. 2006. Andrographolide inhibits the production of TNF-alpha and interleukin-12 in lipopolysaccharide-stimulated macrophages: Role of mitogen-activated protein kinases. Biological & Pharmaceutical Bulletin 2: 220–224.CrossRef Qin, L.H., L. Kong, G.J. Shi, Z.T. Wang, and B.X. Ge. 2006. Andrographolide inhibits the production of TNF-alpha and interleukin-12 in lipopolysaccharide-stimulated macrophages: Role of mitogen-activated protein kinases. Biological & Pharmaceutical Bulletin 2: 220–224.CrossRef
38.
go back to reference Laird, M.H., S.H. Rhee, D.J. Perkins, A.E. Medvedev, W. Piao, M.J. Fenton, and S.N. Vogel. 2009. TLR4/MyD88/PI3K interactions regulate TLR4 signaling. Journal of Leukocyte Biology 6: 966–977.CrossRef Laird, M.H., S.H. Rhee, D.J. Perkins, A.E. Medvedev, W. Piao, M.J. Fenton, and S.N. Vogel. 2009. TLR4/MyD88/PI3K interactions regulate TLR4 signaling. Journal of Leukocyte Biology 6: 966–977.CrossRef
39.
go back to reference Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nature Reviews. Immunology 2: 135–145.CrossRef Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nature Reviews. Immunology 2: 135–145.CrossRef
40.
go back to reference Trinchieri, G., and A. Sher. 2007. Cooperation of toll-like receptor signals in innate immune defence. Nature Reviews. Immunology 3: 179–190.CrossRef Trinchieri, G., and A. Sher. 2007. Cooperation of toll-like receptor signals in innate immune defence. Nature Reviews. Immunology 3: 179–190.CrossRef
41.
go back to reference Chan, E.D., and D.W. Riches. 2001. IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. American Journal of Physiology. Cell Physiology 3: C441–C450.CrossRef Chan, E.D., and D.W. Riches. 2001. IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. American Journal of Physiology. Cell Physiology 3: C441–C450.CrossRef
42.
go back to reference Hattori, Y., S. Hattori, and K. Kasai. 2003. Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation. European Journal of Pharmacology 2–3: 153–158.CrossRef Hattori, Y., S. Hattori, and K. Kasai. 2003. Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation. European Journal of Pharmacology 2–3: 153–158.CrossRef
Metadata
Title
Anti-Inflammatory Effects of Hypophyllanthin and Niranthin Through Downregulation of NF-κB/MAPKs/PI3K-Akt Signaling Pathways
Authors
Hemavathy Harikrishnan
Ibrahim Jantan
Md. Areeful Haque
Endang Kumolosasi
Publication date
01-06-2018
Publisher
Springer US
Published in
Inflammation / Issue 3/2018
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0752-4

Other articles of this Issue 3/2018

Inflammation 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.